Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Kyowa Kirin Co., Ltd., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in Japan (JP) and operates extensively across Asia, Europe, and the Americas. Founded in 1949, the company has achieved significant milestones, including advancements in biopharmaceuticals and innovative drug development.
Kyowa Kirin focuses on core therapeutic areas such as oncology, nephrology, and immunology, offering unique products that leverage cutting-edge biotechnology. Their commitment to research and development has positioned them as a leader in the market, with notable achievements in creating treatments that address unmet medical needs. With a strong emphasis on quality and innovation, Kyowa Kirin continues to enhance patient outcomes globally.
+27 vs industry average
Kyowa Kirin’s score of 69 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing has above-average carbon intensity
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Kyowa Kirin, a Pharmaceutical Preparation Manufacturing company based in Japan, reported its latest Scope 1 emissions as 16,133,000 kg CO2e and Scope 2 emissions as 38,299,000 kg CO2e for the year 2025.
The company has set several climate commitments. As a current subsidiary of Kyowa Kirin Co., Ltd., some initiatives are cascaded. Kyowa Kirin aims to reduce its Scope 1 and Scope 2 CO2 emissions by 55% from 2019 levels by 2030. An interim target includes a 51% reduction in Scope 1 and Scope 2 CO2 emissions by 2024 compared to 2019. Furthermore, the company, as part of the Kirin Group Environmental Vision 2050, is committed to achieving net-zero greenhouse gas emissions across its entire value chain by 2050.
Historically, Kyowa Kirin also aimed to reduce CO2 emissions by 3% from fiscal 2007 levels (16.2% from fiscal 1990 levels) by fiscal 2012 for both Scope 1 and Scope 2.
2030
42% reduction in Scope 1
2030
42% reduction in Scope 2
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Kyowa Kirin’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more